Postoperative external beam radiotherapy for locoregional control in iodine refractory differentiated thyroid cancer

by Andries H Groen, Deborah van Dijk, Wim Sluiter, Thera P Links, Hendrik P Bijl, John T M Plukker
Published 2023-01-01

A sensitive Tg assay or rhTSH stimulated Tg: what's the best in the long-term follow-up of patients with differentiated thyroid carcinoma?

by Adrienne C M Persoon, Pieter L Jager, Wim J Sluiter, John T M Plukker, Bruce H R Wolffenbuttel, Thera P Links
Published 2007-01-01

Role of mTOR through Autophagy in Esophageal Cancer Stemness

by Liang Du, Da Wang, Peter W. Nagle, Andries A. H. Groen, Hao Zhang, Christina T. Muijs, John Th. M. Plukker, Robert P. Coppes
Published 2022-04-01

Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with ¹⁸F-FDG PET Radiomics Based Machine Learning Classification

by Roelof J. Beukinga, Floris B. Poelmann, Gursah Kats-Ugurlu, Alain R. Viddeleer, Ronald Boellaard, Robbert J. De Haas, John Th. M. Plukker, Jan Binne Hulshoff
Published 2022-04-01

Hedgehog Pathway as a Potential Intervention Target in Esophageal Cancer

by Da Wang, Peter W. Nagle, Helena H. Wang, Justin K. Smit, Hette Faber, Mirjam Baanstra, Arend Karrenbeld, Roland K. Chiu, John Th.M. Plukker, Robert P. Coppes
Published 2019-06-01

Recombinant TSH stimulated remnant ablation therapy in thyroid cancer: the success rate depends on the definition of ablation success--an observational study.

by Anouk N A van der Horst-Schrivers, Wim J Sluiter, Anneke C Muller Kobold, Bruce H R Wolffenbuttel, John T M Plukker, Peter H Bisschop, John M de Klerk, Imad Al Younis, Paul Lips, Jan W Smit, Adrienne H Brouwers, Thera P Links
Published 2015-01-01